DeNovaMed is an early-stage pharmaceutical company.
DeNovaMed is an early-stage pharmaceutical company specializing in new therapeutic approaches to combat bacterial infections. Their team has deep domain expertise in drug discovery, microbiology, and bacterial lipid metabolism, which they use to create novel antibiotics. DeNovaMed is based in Halifax, Nova Scotia, Canada.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 31, 2012 | Seed | $500K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innovacorp | — | Seed |